Boundless Bio, Inc. (BOLD)
BOLD Stock Price Chart
Explore Boundless Bio, Inc. interactive price chart. Choose custom timeframes to analyze BOLD price movements and trends.
BOLD Company Profile
Discover essential business fundamentals and corporate details for Boundless Bio, Inc. (BOLD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
20 Jul 2016
Employees
64.00
Website
https://boundlessbio.comCEO
Zachary Hornby
Description
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California.
BOLD Financial Timeline
Browse a chronological timeline of Boundless Bio, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.53.
Earnings released on 5 Aug 2025
EPS came in at -$0.70 surpassing the estimated -$0.75 by +6.67%.
Earnings released on 9 May 2025
EPS came in at -$0.71 falling short of the estimated -$0.68 by -4.41%.
Earnings released on 27 Mar 2025
EPS came in at -$0.74 matching the estimated -$0.74.
Earnings released on 7 Nov 2024
EPS came in at -$0.74 surpassing the estimated -$0.76 by +2.63%.
Earnings released on 12 Aug 2024
EPS came in at -$0.77 surpassing the estimated -$0.78 by +1.28%.
Earnings released on 13 May 2024
EPS came in at -$12.27 falling short of the estimated -$0.55 by -2.13K%.
Earnings released on 31 Dec 2023
EPS came in at -$0.55 .
Earnings released on 30 Sept 2023
EPS came in at -$0.59 .
Earnings released on 30 Jun 2023
EPS came in at -$0.56 .
Earnings released on 30 Mar 2023
EPS came in at -$0.53 .
Earnings released on 31 Dec 2022
EPS came in at -$0.53 .
Earnings released on 29 Sept 2022
EPS came in at -$0.59 .
BOLD Stock Performance
Access detailed BOLD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.